Results 81 to 90 of about 50,280 (120)

Prevalence and Patterns of Potentially Inappropriate Prescribing by Brazilian Dentists for Pediatric Patients: A Cross-Sectional Study. [PDF]

Biomed Res Int
Garcez WEPB, Abdullah F, Reis-Oliveira J, Tavares MA, Abreu MHNG.   +4 more
europepmc   +1 more source

Anti-amyloid therapies in the Brazilian public health system: challenges and barriers. [PDF]

Lancet Reg Health Am
Castilhos RM, Resende E, Studart Neto A.
europepmc   +1 more source

Organosilane for surface cleaning in intensive care units: protocol for a cluster randomized controlled trial with crossover. [PDF]

Crit Care Sci
Nassar Junior AP, Silva CV, Righi CG, Bezerra IL, Carvalho A, Patrocínio ACL, Souza EMC, Rodrigues MB, Santos TMD, Oliveira LFV, Christoff AP, Teixeira BL, Besen BAMP, Veiga VC, Cavalcanti AB, Tomazini BM, Pereira AJ.   +16 more
europepmc   +1 more source

[Experiences and Challenges of the Ecuadorean National Advisory Commission on Serious Events Supposedly Attributable to Vaccination or Immunization, 2020-2023Experiências e desafios da Comissão Consultiva Nacional sobre Eventos Supostamente Atribuíveis à Vacinação ou Imunização graves do Equador, 2020-2023]. [PDF]

Rev Panam Salud Publica
Simancas-Racines D, Parise-Vasco JM, Baldeón-Espinosa S, Aguinaga RR, Vinueza-Valencia G, Jacome C, Zurita J, Bejar C, Bayas L, Pérez-Tasigchana F, Anchayhua Y, Pinto-Díaz CA, Molina-León HF, Baquero-Paret G.   +13 more
europepmc   +1 more source

How the Stakeholders' Perception Contributes to the Pharmaceutical Strategies: A Regional Case Study in Latin America. [PDF]

J Mark Access Health Policy
Ferreira TDS, Pauletti GM, Vázquez-Suárez L.   +2 more
europepmc   +1 more source

[Distribution of the COVID-19 vaccine: experience in EcuadorOperacionalização da vacinação contra a COVID‑19: experiência no Equador]. [PDF]

Rev Panam Salud Publica
Ruales J, Garzón X, Aldaz C, Vásconez N, Jácome F, Cevallos J, Pinos J, Pérez-Tasigchana F, Díaz A, Whittembury A.   +9 more
europepmc   +1 more source

Medicines withdrawn in other countries due to safety problems, between 2014 and 2023, and their permanence in the Argentine market. [PDF]

Rev Fac Cien Med Univ Nac Cordoba
Caffaratti M, Cañás M, Domosbian DE, Giraudo E, González AM, Lorenzo A, Núñez Montoya S, Rocha MT, Traverso ML, Uema S.   +9 more
europepmc   +1 more source

Advancing real-world evidence in Brazil: regulatory gaps and global lessons. [PDF]

Lancet Reg Health Am
Cézar de Aquino N, Reichert CO, Alberto de Padua Covas Lage L, Culler HF, Rosa Roitberg FS, Rocha V, Rocha Alves FN, Pereira J.   +7 more
europepmc   +1 more source

[Analysis of the surveillance system for adverse events following Immunization (AEFI) related to COVID-19 vaccines in Colombia, 2021-2023Análise do sistema de vigilância de ESAVI por vacinas contra a COVID-19 na Colômbia, 2021-2023]. [PDF]

Rev Panam Salud Publica
Saza-Londoño W, Pinzón-Fajardo DY, Urrea-Duque MV, Pinzón-Niño EL, Sánchez-León EM, Urieles-Sierra KI, Pinto-Díaz CA, Molina-León HF.   +7 more
europepmc   +1 more source